Kazakhstan: a “bitter pill” for investors in the pharmaceutical market

Kazakhstan: a “bitter pill” for investors in the pharmaceutical market

Special Edition. Corruption and unpredictable government policies pose serious obstacles to the work of investors in Kazakhstan. The change in the rules of cooperation with foreign investors in the pharmaceutical sector, made by the state, calls into question their further presence in Kazakhstan.

Select the amount of a one-time donation in Bitcoin